DXCM - Dexcom Inc
(NaN%)
SNP 500NASDAQ
Hold
Strong Growth but Declining
74%
based on last 5 year data.
Income Statement is STRONG
Revenue Growth is 15.6%
Operating Income Growth is 51.97%
Net Income Growth is 45.14%
Earnings Per Share (EPS) Growth is 47.18%
Net Margin is 17.94%
Balance Sheet is STRONG
Current Asset to Current Liability Ratio is 1.88
Debt Ratio is 0.57
Current Debt to Net Income Ratio is 0.0
Total Debt to Total Assets Ratio is 0.0
Cash Flow is MODERATE
Cash from Operations Growth is 45.6%
Capital Expenditure is High
Net Increase in Cash is Positive
Long Term Score Trend is NEGATIVE
Investment Risk is Moderate
based on last 4 quarter data.
Better viewed in landscape mode.
Unless specified, all values are in USD Millions. Data extracted from SEC Filing and are subject to processing and input errors.
Dexcom Inc (DXCM) - http://www.dexcom.com/
founded in 1999, dexcom, inc provides continuous glucose monitoring technology to help patients and their clinicians better manage diabetes. since our inception, we have focused on better outcomes for patients, caregivers, and clinicians by delivering solutions for people with diabetes — while empowering our community to take control of diabetes.Exchange - NASDAQ
Industry - Surgical and Medical Instrument Manufacturing
Sector - Manufacturing
CEO - Kevin Sayer
Employees - 5,328
Disclaimer - Investment in securities involves substantial risk and could result in significant loss. It is not suitable for every investor. Before acting on information on this website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser. We may own some of the securities mentioned in this website.
Know the Stock © 2026 and future.
Know the Stock © 2026 and future.